AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28663405 — intervention group
Group type: COMPARATOR
Intervention: Operative management (n = 11; tension-band wiring n = 9, plate n = 2)
Number of subjects: 19
Study 28663405 — intervention group
Group type: COMPARATOR
Intervention: Operative management (n = 11)
Number of subjects: 19
Study 26004924 — intervention group
Group type: EXPERIMENTAL
Intervention: Frailty education module (online short course)
Number of subjects: 41
Study 23524525 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 15 mg twice a day
Number of subjects: 0
Study 23524525 — intervention group
Group type: COMPARATOR
Intervention: Glibenclamide 5 mg twice a day
Number of subjects: 0
Study 23524525 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg added after 6 months
Number of subjects: 0
Study 21330267 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone counseling
Number of subjects: 1202
Study 21330267 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based services
Number of subjects: 1202
Study 21330267 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined phone-Web
Number of subjects: 1202
Study 21330267 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone and Web services
Number of subjects: 1202
Study 21330267 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age and belief in treatment effectiveness
Number of subjects: 1202
Study 19689817 — intervention group
Group type: EXPERIMENTAL
Intervention: T SPOT TB test
Number of subjects: 0
Study 19689817 — intervention group
Group type: COMPARATOR
Intervention: T ST test
Number of subjects: 0
Study 15691552 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 0.02% mitomycin C
Number of subjects: 36
Study 15691552 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid treatment (fluorometholone sodium 2%)
Number of subjects: 36
Study 12535750 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial triglycerides in diabetic subjects
Number of subjects: 16
Study 12535750 — intervention group
Group type: COMPARATOR
Intervention: Postprandial triglycerides in control subjects
Number of subjects: 16
Study 12535750 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipose tissue LPL activity post-meal test
Number of subjects: 16
Study 12535750 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting and postprandial adipose tissue LPL activity
Number of subjects: 16
Study 10795802 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Manipulation Test (VMT) administered to children
Number of subjects: 193
Study 10795802 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Manipulation Test (VMT) retest
Number of subjects: 193
Study 8800868 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy (Arm II)
Number of subjects: 100
Study 8800868 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (Arm I)
Number of subjects: 100
Study 1676394 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 0.25 mg (IB)
Number of subjects: 15
Study 1676394 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutalin 2.5 mg (TER)
Number of subjects: 15
Study 1676394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential inhalation of IB after TER
Number of subjects: 15
Study 1676394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential inhalation of TER after IB
Number of subjects: 15
Study 1676394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both agents (IB and TER)
Number of subjects: 15
Study 6605370 — intervention group
Group type: EXPERIMENTAL
Intervention: PABA ester‐oxybenzone preparation
Number of subjects: 0
Study 6605370 — intervention group
Group type: COMPARATOR
Intervention: PABA
Number of subjects: 0
Study 6605370 — intervention group
Group type: COMPARATOR
Intervention: sulisobenzone
Number of subjects: 0
Study 31559413 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed meat products (hot dog, bacon)
Number of subjects: 12
Study 27138245 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated health education and elastic band resistance training program for 18 weeks (8 weeks supervised, 10 weeks self-directed)
Number of subjects: 38
Study 27138245 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-directed exercise after 8 weeks of supervised training
Number of subjects: 38
Study 27138245 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 38
Study 25674675 — intervention group
Group type: EXPERIMENTAL
Intervention: home blood pressure telemonitoring alone
Number of subjects: 28
Study 25674675 — intervention group
Group type: EXPERIMENTAL
Intervention: home blood pressure telemonitoring plus telephone‐based nurse case management
Number of subjects: 28
Study 24512496 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEA (130 mg for 5 days)
Number of subjects: 28
Study 24512496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 24512496 — intervention group
Group type: EXPERIMENTAL
Intervention: MNC exposure to T concentrations of 125 and 250 ng/dL
Number of subjects: 28
Study 24512496 — intervention group
Group type: EXPERIMENTAL
Intervention: MNC exposure to DHEA concentration of 1750 ng/dL
Number of subjects: 28
Study 24512496 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutamide preincubation
Number of subjects: 28
Study 22678971 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioral intervention, 45 minutes, twice weekly for 5 weeks
Number of subjects: 55
Study 22678971 — intervention group
Group type: EXPERIMENTAL
Intervention: Working Alliance Inventory (WAI)
Number of subjects: 55
Study 19036552 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐week individual pedometer‐based exercise counseling program
Number of subjects: 35
Study 19036552 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 35
Study 17321310 — intervention group
Group type: EXPERIMENTAL
Intervention: Circumcision
Number of subjects: 2784
Study 17321310 — intervention group
Group type: COMPARATOR
Intervention: Delayed circumcision (Control)
Number of subjects: 2784
Study 15918384 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 500 mL
Number of subjects: 14
Study 15918384 — intervention group
Group type: COMPARATOR
Intervention: Gelatine 500 mL
Number of subjects: 14
Study 12707718 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral eniluracil (EU) 20 mg plus LV 30 mg on days 1-3 with a single dose of 5-FU 15-29 mg/m2 on day 2
Number of subjects: 26
Study 12707718 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucovorin (LV) 30 mg on days 1-2 with a single dose of EU at least 1 h prior to 5-FU 29 mg/m2 on day 2 weekly for 3 of 4 weeks
Number of subjects: 26
Study 12707718 — intervention group
Group type: COMPARATOR
Intervention: 5-FU 2300 mg/m2 as a pharmacokinetic reference
Number of subjects: 26
Study 10655927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.1 mg kg‐1
Number of subjects: 30
Study 10655927 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 30
Study 8906139 — intervention group
Group type: EXPERIMENTAL
Intervention: Similac Natural Care (NC)
Number of subjects: 59
Study 8906139 — intervention group
Group type: EXPERIMENTAL
Intervention: Enfamil Powder (EP)
Number of subjects: 59
Study 8906139 — intervention group
Group type: COMPARATOR
Intervention: Both NC and EP
Number of subjects: 59
Study 2060339 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2060339 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of inhaled verapamil
Number of subjects: 10
Study 2060339 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest dose of verapamil tolerated (20 to 160 mg)
Number of subjects: 10
Study 6339939 — intervention group
Group type: EXPERIMENTAL
Intervention: True plasmapheresis therapy
Number of subjects: 26
Study 6339939 — intervention group
Group type: COMPARATOR
Intervention: Sham plasmapheresis therapy
Number of subjects: 26
Study 30543021 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 222
Study 30543021 — intervention group
Group type: COMPARATOR
Intervention: Light-touch
Number of subjects: 222
Study 30543021 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 222
Study 30268162 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe Vera gel applied twice a day on hip, sacrum, and heel
Number of subjects: 80
Study 30268162 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gel of water and starch)
Number of subjects: 80
Study 30268162 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe Vera gel
Number of subjects: 80
Study 26370072 — intervention group
Group type: EXPERIMENTAL
Intervention: Dental treatment for dental caries
Number of subjects: 100
Study 25249234 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceylon cinnamon hydro‐alcoholic extract (CCE) 1 g
Number of subjects: 18
Study 25249234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 22264617 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol A (maximum temperature starting at 43°C)
Number of subjects: 10
Study 22264617 — intervention group
Group type: COMPARATOR
Intervention: Protocol B (near body temperature starting at 41°C)
Number of subjects: 10
Study 20406269 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants
Number of subjects: 35122
Study 20406269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35122
Study 17268082 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg), riboflavin (10 mg), niacin (50 mg) along with tamoxifen (10 mg twice a day) for 45 days
Number of subjects: 84
Study 17268082 — intervention group
Group type: EXPERIMENTAL
Intervention: Coenzyme Q10 (100 mg), riboflavin (10 mg), niacin (50 mg) along with tamoxifen (10 mg twice a day) for 90 days
Number of subjects: 84
Study 17268082 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen therapy alone for more than 1 year
Number of subjects: 84
Study 16119478 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine
Number of subjects: 18
Study 16119478 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (l allele)
Number of subjects: 18
Study 16119478 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine (s allele)
Number of subjects: 18
Study 16119478 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12394789 — intervention group
Group type: EXPERIMENTAL
Intervention: Stavudine (d4T) monotherapy
Number of subjects: 26
Study 10435237 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based early detection intervention for cervical cancer
Number of subjects: 0
Study 10435237 — intervention group
Group type: EXPERIMENTAL
Intervention: Community and cultural factors
Number of subjects: 0
Study 7763068 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth hormone treatment (Genotropin 30 IU/m2/week)
Number of subjects: 28
Study 7763068 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 28
Study 2279745 — intervention group
Group type: EXPERIMENTAL
Intervention: Alclometasone dipropionate cream 0.1%
Number of subjects: 39
Study 2279745 — intervention group
Group type: COMPARATOR
Intervention: Hydrocortisone butyrrate
Number of subjects: 39
Study 113096 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine at 6 mg/kg/day orally for 21 days every 4 weeks
Number of subjects: 34
Study 113096 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine at 8 mg/kg/day orally for 21 days every 6 weeks
Number of subjects: 34
Study 113096 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexamethylmelamine
Number of subjects: 34
Study 29099329 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy with carbon dioxide pneumoperitoneum (CDP)
Number of subjects: 86
Study 29099329 — intervention group
Group type: COMPARATOR
Intervention: Control group (laparotomy without CDP)
Number of subjects: 86
Study 27147621 — intervention group
Group type: EXPERIMENTAL
Intervention: Fumaric acid esters (FAEs)
Number of subjects: 11
Study 25681735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT) prior to extinction training on Day 1
Number of subjects: 40
Study 25681735 — intervention group
Group type: COMPARATOR
Intervention: Control procedure prior to extinction training on Day 1
Number of subjects: 40
Study 25681735 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test (CPT)
Number of subjects: 40
Study 23669000 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of tranexamic acid
Number of subjects: 400
Study 23669000 — intervention group
Group type: COMPARATOR
Intervention: Saline (Placebo)
Number of subjects: 400
Study 20668790 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment that enquires directly into childhood trauma and understands present interpersonal difficulties as a compulsion to repeat the traumatic past.
Number of subjects: 87
Study 20668790 — intervention group
Group type: COMPARATOR
Intervention: Usual management (control group).
Number of subjects: 87
Study 20668790 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment costs.
Number of subjects: 87
Study 20668790 — intervention group
Group type: COMPARATOR
Intervention: Control treatment costs.
Number of subjects: 87
Study 20668790 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per patient recovered in experimental group.
Number of subjects: 87
Study 20668790 — intervention group
Group type: COMPARATOR
Intervention: Cost per patient recovered in control group.
Number of subjects: 87
Study 18097675 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard colonoscope
Number of subjects: 650
Study 18097675 — intervention group
Group type: COMPARATOR
Intervention: Upper GI scope
Number of subjects: 650
Study 16166579 — intervention group
Group type: EXPERIMENTAL
Intervention: tPA treatment
Number of subjects: 608
Study 14640390 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription of efavirenz to NNRTI-naive patients
Number of subjects: 541
Study 14640390 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization to the genotyping arm
Number of subjects: 541
Study 14640390 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription of lamivudine
Number of subjects: 541
Study 14640390 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescription of abacavir to abacavir-naive patients
Number of subjects: 541
Study 14640390 — intervention group
Group type: COMPARATOR
Intervention: Prescription of nelfinavir
Number of subjects: 541
Study 14640390 — intervention group
Group type: COMPARATOR
Intervention: High baseline viral load
Number of subjects: 541
Study 14640390 — intervention group
Group type: COMPARATOR
Intervention: Presence of at least five PI mutations
Number of subjects: 541
Study 14640390 — intervention group
Group type: COMPARATOR
Intervention: Presence of at least three thymidine analogue mutations
Number of subjects: 541
Study 14640390 — intervention group
Group type: COMPARATOR
Intervention: At least 30 months of prior PI exposure
Number of subjects: 541
Study 10672626 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 25 mg
Number of subjects: 12
Study 10672626 — intervention group
Group type: EXPERIMENTAL
Intervention: Sibutramine 75 mg
Number of subjects: 12
Study 10672626 — intervention group
Group type: COMPARATOR
Intervention: d‐amphetamine 20 mg
Number of subjects: 12
Study 10672626 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8654328 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) at a ratio of 15:15 (15g MCT, 15g long-chain triglycerides)
Number of subjects: 8
Study 8654328 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) at a ratio of 30:0 (30g MCT, 0g long-chain triglycerides)
Number of subjects: 8
Study 8654328 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) at a ratio of 5:25 (5g MCT, 25g long-chain triglycerides)
Number of subjects: 8
Study 8654328 — intervention group
Group type: COMPARATOR
Intervention: Medium-chain triglycerides (MCT) at a ratio of 0:30 (0g MCT, 30g long-chain triglycerides)
Number of subjects: 8
Study 8654328 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-chain triglycerides (MCT) at ratios of 15:15 and 30:0
Number of subjects: 8
Study 1386491 — intervention group
Group type: EXPERIMENTAL
Intervention: Candoxatril (150 mg twice daily)
Number of subjects: 12
Study 6654301 — intervention group
Group type: EXPERIMENTAL
Intervention: Etofenamate cream
Number of subjects: 60
Study 6654301 — intervention group
Group type: COMPARATOR
Intervention: Control medication (salicylic acid ointment)
Number of subjects: 60
Study 30206086 — intervention group
Group type: EXPERIMENTAL
Intervention: Home assessment and modification
Number of subjects: 1299
Study 30206086 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1299
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 120s with 1.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 120s with 0.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 120s with 1.5g of 250ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 45s with 1.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 45s with 0.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 120s with 1.5g of 1150ppm F dentifrice vs brushing for 120s with 0.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 27717756 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing for 45s with 1.5g of 1150ppm F dentifrice vs brushing for 45s with 0.5g of 1150ppm F dentifrice
Number of subjects: 63
Study 24835473 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-cm training group
Number of subjects: 36
Study 24835473 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-cm training group
Number of subjects: 36
Study 24835473 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study 21815838 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX Unicem, 3M Espe)
Number of subjects: 40
Study 21815838 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (SmartCem 2, Dentsply)
Number of subjects: 40
Study 21815838 — intervention group
Group type: EXPERIMENTAL
Intervention: Etch-and-rinse adhesive system with core-and-post material (XP Bond + SCA/Core-X flow, Densply)
Number of subjects: 40
Study 21815838 — intervention group
Group type: COMPARATOR
Intervention: Etch-and-rinse adhesive system with core-and-post material (DentinBond/DentinBuild, Komet)
Number of subjects: 40
Study 21815838 — intervention group
Group type: COMPARATOR
Intervention: Self-etch adhesive/resin cement (ED-Primer II/Panavia F 2.0, Kuraray)
Number of subjects: 40
Study 20170881 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g vitamin C infusion (16.6 mg/min, over 1 h before percutaneous coronary intervention)
Number of subjects: 56
Study 20170881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 20170881 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g vitamin C infusion
Number of subjects: 56
Study 19011435 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion added to nicotine replacement therapy (NRT) and cognitive behavioral therapy (CBT)
Number of subjects: 199
Study 19011435 — intervention group
Group type: COMPARATOR
Intervention: Placebo added to nicotine replacement therapy (NRT) and cognitive behavioral therapy (CBT)
Number of subjects: 199
Study 15708261 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (C) - 40 mg/m² weekly for 6 doses concurrent with 50 Gy external beam radiotherapy
Number of subjects: 83
Study 15708261 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus Gemcitabine (GC) - Gemcitabine 125 mg/m² plus Cisplatin 40 mg/m² weekly for 6 doses concurrent with 50 Gy external beam radiotherapy
Number of subjects: 83
Study 14526206 — intervention group
Group type: EXPERIMENTAL
Intervention: Tools for Health and Empowerment HIV education intervention plus routine counseling (EI + RC; n = 96)
Number of subjects: 195
Study 14526206 — intervention group
Group type: COMPARATOR
Intervention: Routine counseling alone (RC; n = 99)
Number of subjects: 195
Study 11780187 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 6749
Study 11780187 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6749
Study 9400406 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with oxytocin (IwO)
Number of subjects: 0
Study 9400406 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction with prostaglandin (IwP)
Number of subjects: 0
Study 9400406 — intervention group
Group type: COMPARATOR
Intervention: Expectant management with oxytocin (EM-O)
Number of subjects: 0
Study 9400406 — intervention group
Group type: COMPARATOR
Intervention: Expectant management with prostaglandin (EM-P)
Number of subjects: 0
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: Low anxiety/attention directed towards pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: Low anxiety/attention distracted from pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: High anxiety/attention directed towards pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: High anxiety/attention distracted from pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin Conductance Response (SCR) when distracted from pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin Conductance Response (SCR) when attending to pain
Number of subjects: 24
Study 8510069 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety influence on pain responses
Number of subjects: 24
Study 3690975 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic saline (3% NaCl)
Number of subjects: 6
Study 3690975 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.9% NaCl)
Number of subjects: 6
Study 31676693 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight Control (TC)
Number of subjects: 78
Study 31676693 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (StdC)
Number of subjects: 78
Study 31370975 — intervention group
Group type: EXPERIMENTAL
Intervention: Fathers for Change (F4C)
Number of subjects: 62